Clin2
NCT06821529Possibly a fitNot yet recruiting

New cell injection for Parkinson's disease

Parkinson Disease

Part of Brain & nervous system clinical trials.

This trial tests a new treatment made from special cells injected into the brain to help people with Parkinson's disease who take levodopa but still have complications like wearing off or involuntary movements.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
12 people
Ages
39 years to 75 years
Study type
Interventional

Who can take part

  • You must be between 39 and 75 years old and have had Parkinson's for over 5 years.
  • You should be taking levodopa, but still have

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07212088Not yet recruiting· Phase 1
Brain cell injection for Parkinson's disease

This trial tests whether injecting special cells into the brain can improve Parkinson's symptoms. It is for people who have had Parkinson's for at least 5 years, take levodopa but still have times when the medication wears off or causes uncontrolled movements.

Hangzhou, Zhejiang
NCT06687837Recruiting· Phase 1
Stem cell therapy for Parkinson's disease

This trial tests whether implanting your own stem cells (made into dopamine-producing brain cells) can improve Parkinson's motor symptoms. You would need to be a candidate for brain surgery and have a stable medication routine.

Boston, Massachusetts
NCT07102342Recruiting· Phase 1/Phase 2
Cell therapy for Parkinson's disease

This trial tests a new cell treatment for Parkinson's disease. It involves injecting special cells into the brain to see if they can safely replace damaged cells and improve symptoms. It might help people who have had Parkinson's for several years and still respond well to medication.

New York, New York
NCT06344026Enrolling by invitation· Phase 1
A cell therapy trial for Parkinson's disease

This trial tests a new treatment made from your own cells to replace damaged brain cells, aiming to improve movement and reduce symptoms. It's for people who have had Parkinson's for at least 4 years and respond well to levodopa.

Tucson, Arizona
NCT06167681Recruiting· Phase 1/Phase 2
Cell Therapy NouvNeu001 for Parkinson's Disease

This trial tests a new cell therapy called NouvNeu001 for Parkinson's disease. It involves a one-time brain surgery to deliver the treatment, and researchers will check if it's safe and helps with symptoms.

Beijing, Beijing Municipality
NCT06583291Not yet recruiting· Early Phase 1
iDAP Injection for Parkinson's Disease

This trial tests an injected medication called iDAP for people with moderate-stage Parkinson's disease. It aims to see if iDAP can improve movement symptoms when added to your current treatment.

Hear when a new Parkinson Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.